|
1）Neukirchen J, Schoonen WM, Strupp C, et al. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-Registry. Leuk Res. 2011; 35: 1591-6
|
|
|
|
2）Iwanaga M, Hsu WL, Soda M, et al. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 2011; 29: 428-34
|
|
|
|
|
|
3）Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma, multiple myeloma, 1950-1987. Radiat Res. 1994; 137(2 Suppl): S68-97
|
|
|
|
|
|
4）Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors: Report 12, Part I. Cancer. Radiat Res. 1996; 146(1): 1-27
|
|
|
|
|
|
5）ICRP Report 2007
|
|
|
|
|
|
6）Nakashima M, Kondo H, Miura S, et al. Incidence of multiple cancers in Nagasaki atomic bomb survivors: association with radiation exposure. Cancer Sci. 2008; 99: 87-92
|
|
|
|
|
7）Yamashita S, Saenko V. Mechanism of disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab. 2007; 3: 422-9
|
|
|
|
|
|
8）Amenomori T, Honda T, Otake M, et al. Growth and differentiation of circulating hematopoietic stem cells with atomic bomb irradiation-induced chromosome abnormalities. Exp Hematol. 1988; 16: 849-54
|
|
|
|
|